Synthetic glucocorticoids are widely used for their anti-inflammatory and
immunosuppressive actions. A possible unwanted effect of glucocorticoid treatment is …

Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality,
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …

Asthma is a common inflammatory airway disease for which the most commonly used
controller medications are inhaled corticosteroids (ICS). Asthma control is difficult to achieve …

Glucocorticoids are the most commonly prescribed anti-inflammatory/immunosuppressant
medications worldwide. This article highlights the risk of clinically significant and sometimes …

The goal of asthma treatment is to obtain clinical control and reduce future risks to the
patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all …

Despite the availability of several formulations of inhaled corticosteroids (ICS) and delivery
devices for treatment of childhood asthma and despite the development of evidence-based …

Although montelukast is generally well tolerated, postmarketing studies have reported
serious neuropsychiatric adverse drug reactions (ADRs) leading to a United States Food …

Central adrenal insufficiency (CAI) is a life-threatening condition caused by either pituitary
disease (secondary adrenal insufficiency) or impaired hypothalamic function with …

Glucocorticoid-induced adrenal insufficiency is caused by exogenous glucocorticoid
suppression of the hypothalamic-pituitary-adrenal axis and is the most prevalent form of …

Adrenal crises (AC) are life-threatening physiological disturbances that occur at a rate of 5–
10/100 patient years in patients with adrenal insufficiency (AI). Despite their seriousness …